(Press-News.org) A gene not previously linked to cancer has been shown to play a key role in the spread of certain cancers to the lungs, new research from scientists at the Wellcome Sanger Institute has shown. The team found that when the gene LRRN4CL was over-expressed in mice, the skin cancer melanoma was more likely to metastasise to the lungs.
The study, published today (23 March 2021) in Communications Biology, also confirmed that over-expression of LRRN4CL was linked to metastasis of colon, breast and bladder cancers to the lung.
Several factors make LRRN4CL an attractive drug target. It encodes a protein found on the surface of cancer cells, making it easier to target with drugs. And because it is expressed at low levels elsewhere in the body, it may be possible to target LRRN4CL without causing serious side effects for the patient.
Metastasis is when cancers spread from one organ to other parts of the body via the blood and lymphatic systems. Once cancer cells are mobile, they can take root in other organs and form secondary tumours, most commonly in the lungs.
Metastasis makes cancers much harder to treat and is associated with much poorer outcomes for patients. Metastasis is the reason why melanoma, which accounts for around five per cent of skin cancers, also accounts for the majority of skin cancer deaths. Whereas basal cell skin cancer, which is the most common form of the disease, rarely spreads and is rarely life-threatening*.
In this study, scientists at the Wellcome Sanger Institute set out to identify genes whose over-expression - an increase in activity compared to the gene's normal functioning - resulted in the increased ability of melanoma cells to spread to the lungs in mice.
They conducted a CRISPR activation (CRISPRa) screen on genes that encode proteins on the surface of the cell, boosting the level of expression of the genes one by one to observe which had an effect.
The team found that over-expression of the gene LRRN4CL increased the ability of mouse and human melanoma cells to metastasise to the lungs. They also tested cell models for colon, breast and bladder cancer, confirming the role of LRRN4CL in metastasis to the lungs in all of them. This is the first time that LRRN4CL has been linked to cancer.
Dr Louise van der Weyden, first author of the paper from the Wellcome Sanger Institute, said: "Metastasis is a complex phenomenon, and metastatic cells can have different characteristics depending on the original cancer type, the secondary tumour location and even the age of the patient. However, our findings show that when metastatic cancer cells of the skin, colon or breast express high levels of LRRN4CL, it makes them uniquely able to survive and grow in the lung."
The researchers also checked databases of gene expression in patient tumours and found that melanomas with elevated expression of LRRN4CL correlated with poorer patient outcomes.
Dr Anneliese Speak, an author of the paper from the Wellcome Sanger Institute, said: "Our results suggest that reducing the expression of the LRRN4CL gene could help to prevent metastasis to the lungs, which would already make it a potential drug target. The added bonus is that this gene is expressed at very low levels elsewhere in the body, so hopefully targeting LRRN4CL wouldn't have severe side effects for patients."
Genes that encode cell surface proteins are often attractive drug targets, as the drug only needs to be delivered to the exterior of the cell rather than the interior, making drug design less complex.
Dr David Adams, senior author of the paper from the Wellcome Sanger Institute, said: "Prior to this study, there was nothing in the scientific literature to link the LRRN4CL gene to cancer, much less to suggest that it plays such a pivotal role in metastasis. Part of the power of CRISPR screens is that they don't require a clear hypothesis to create new insights. This is an important discovery that marks LRRN4CL as a promising drug target to help prevent the spread of cancer to the lungs and improve outcomes for patients."
In additional work recently published in Nature Communications, the team used combinatorial CRISPR screening to define gene pairs that represent therapeutic targets in melanoma, thus providing additional targets to treat this complex disease.
INFORMATION:
Contact details:
Dr Matthew Midgley
Press Office
Wellcome Sanger Institute
Cambridge, CB10 1SA
Phone: 01223 494856
Email: press.office@sanger.ac.uk
Notes to Editors:
* The Cancer Research UK blog has more information on metastasis and how it varies in different cancers.
https://scienceblog.cancerresearchuk.org/2019/11/26/science-surgery-why-do-some-cancers-metastasise-but-others-dont/
Publication:
Louise van der Weyden, Victoria Harle and Gemma Turner et al. (2021). CRISPR activation screen in mice identifies novel membrane proteins enhancing pulmonary metastatic colonisation. Communications Biology.
DOI: https://doi.org/10.1038/s42003-021-01912-w
Funding:
This work was funded by Cancer Research UK, ERC Combat Cancer and Wellcome.
Selected websites:
The Wellcome Sanger Institute
The Wellcome Sanger Institute is a world leading genomics research centre. We undertake large-scale research that forms the foundations of knowledge in biology and medicine. We are open and collaborative; our data, results, tools and technologies are shared across the globe to advance science. Our ambition is vast - we take on projects that are not possible anywhere else. We use the power of genome sequencing to understand and harness the information in DNA. Funded by Wellcome, we have the freedom and support to push the boundaries of genomics. Our findings are used to improve health and to understand life on Earth. Find out more at http://www.sanger.ac.uk or follow us on Twitter, Facebook, LinkedIn and on our Blog.
About Wellcome
Wellcome exists to improve health by helping great ideas to thrive. We support researchers, we take on big health challenges, we campaign for better science, and we help everyone get involved with science and health research. We are a politically and financially independent foundation. https://wellcome.org/
WINSTON-SALEM, N.C. - March 22, 2021 - The fear, anxiety and stress associated with the COVID-19 pandemic has taken a toll on mental health. But a new study suggests these symptoms may be alleviated through safe and convenient online mindfulness practices.
The study, which was recently published in the journal Global Advances in Health and Medicine, shows that an online mindfulness intervention may reduce momentary stress, anxiety and COVID-19 concern.
At the onset of the pandemic, Rebecca Erwin Wells, M.D., M.P.H., associate professor of neurology at Wake Forest School of Medicine, part of Wake Forest Baptist Health, and principal investigator ...
Fatigue, depression, sleep disorders, burnout: the number of cases where employees are unable to work for mental health-related reasons has increased dramatically in recent years. Professor Sascha Alavi, Chair at the Sales Management Department (SMD), has long been keeping a critical eye on this development in society, especially in the corporate world. Together with his former PhD student Dr. Kim Linsenmayer and Professor Johannes Habel from the University of Houston, Alavi has now demonstrated in the Journal of Marketing the negative effects that pressure in the form of performance-based remuneration schemes can have on health. Rubin, the science magazine from RUB, reports on this.
In ...
Knee osteoarthritis is a painful condition that affects over 14 million U.S. adults, many of whom have extreme obesity, defined by body mass index (BMI) greater than 40kg/m2. Total knee replacement (TKR) is often recommended to treat advanced knee osteoarthritis, but surgeons may be hesitant to operate on patients with extreme obesity due to concerns about the increased risks of tissue infection, poor wound healing and higher risk of implant failure. Using an established, validated and widely published computer simulation called the Osteoarthritis Policy (OAPol) Model, researchers from Brigham and Women's Hospital, together with collaborators from Yale and Boston University ...
Candidiasis is a fungal infection caused by a yeast called Candida. It is a serious global health problem and it can be vaginal, oral or systemic. The latter is the most severe form of infection, as it can lead to death, but vaginal candidiasis infection is the most prevalent, affecting 80% of women at some point in their lives.
Scientists led by Dr. Toni Gabaldón, ICREA researcher and group leader at the Institute for Research in Biomedicine (IRB Barcelona) and the Barcelona Supercomputing Center (BSC), in collaboration with Dr. Bernhard Hube's group at the Hans Knoell Institute and the University of Jena in Germany, have described the various mechanisms used by the fungus Candida to infect the ...
LA JOLLA, CA--A discovery involving multiple teams from across Scripps Research has revealed a powerful new approach for treating diabetic foot ulcers, which affect millions of people in the US and often lead to serious complications.
By targeting a gene that controls tissue growth and regeneration, the scientists were able to boost cell division at the site of injury and repair chronic wounds quickly. The new research appears in Nature Chemical Biology.
Given the growing prevalence of diabetes and limited options for treating foot ulcers--which can lead to amputation, in severe cases--it's clear that more effective treatments are needed, says chemist Michael ...
Metal-insulator transition (MIT) driven by many-body interactions is an important phenomenon in condensed matter physics. Exotic phases always emerge around the metal-insulator transition points where quantum fluctuations arise from a competition among spin, charge, orbital, and lattice degrees of freedom. Two-dimensional (2D) materials are a large class of materials. Their simple structure, low dimensionality, and highly tunable carrier density make them an ideal platform for exploring exotic phases. However, the many-body interactions are normally weak in most 2D materials, hence, the correlation-related phenomena ...
Call it the evolutionary march of the penguins.
More than 50 million years ago, the lovable tuxedoed birds began leaving their avian relatives at the shoreline by waddling to the water's edge and taking a dive in the pursuit of seafood.
Webbed feet, flipper-like wings and unique feathers all helped penguins adapt to their underwater excursions. But new research from the University of Nebraska-Lincoln has shown that the evolution of diving is also in their blood, which optimized its capture and release of oxygen to ensure that penguins wouldn't waste their ...
LA JOLLA, CA--An analysis of thousands of genomes from people with and without the rare eye disease known as MacTel has turned up more than a dozen gene variants that are likely causing the condition to develop and worsen for a significant share of patients.
The discovery, by a team of scientists from Scripps Research and the Lowy Medical Research Institute, in collaboration with Columbia University in New York and UC San Diego, provides a new avenue to pursue for diagnosis and treatment. It also sheds light on fundamental aspects of metabolism in the retina, a tissue with one of the highest energy demands in the human body. Findings appear today in the journal Nature Metabolism.
"It's exciting to uncover new answers to the ...
The cost of the rechargeable lithium-ion batteries used for phones, laptops, and cars has fallen dramatically over the last three decades, and has been a major driver of the rapid growth of those technologies. But attempting to quantify that cost decline has produced ambiguous and conflicting results that have hampered attempts to project the technology's future or devise useful policies and research priorities.
Now, MIT researchers have carried out an exhaustive analysis of the studies that have looked at the decline in the prices these batteries, which are the dominant rechargeable ...
Stuttgart - A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Germany, from Seoul National University in Korea and from the Harvard University in the US, successfully developed a predictive model and closed-loop controller of a soft robotic fish, designed to actively adjust its undulation amplitude to changing flow conditions and other external disturbances. Their work "Modeling and Control of a Soft Robotic Fish with Integrated Soft Sensing" was published in Wiley's Advanced Intelligent Systems journal, in a special issue on "Energy Storage and Delivery in Robotic Systems".
Each ...
